PALI

$2.01-8.64%

PALISADE BIO, INC.

Market Cap

$357M

Sector

Materials

Industry

Biotechnology

Beta

1.46

5yr monthly vs SPY

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

16 analysts

Buy Activity

Buy Velocity Score

24.85x

Current Rate (90d)

1388.89/mo

Baseline Rate

0.00/mo

Unique Buyers (90d)

2

Sell Activity

Sell Velocity Score

228.37x

Sell Rate (90d)

2207.53/mo

Sell Baseline

24.02/mo

Unique Sellers (90d)

2

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-07-09	2026-07-10	Baltera Robert Jr.	Director	Purchase	25.0K	$1.96	$49K	461.9K	View
2026-07-08	2026-07-10	Baltera Robert Jr.	Director	Purchase	20.0K	$1.99	$40K	436.9K	View
2026-07-07	2026-07-08	Baltera Robert Jr.	Director	Purchase	30.0K	$2.03	$61K	416.9K	View
2026-07-07	2026-07-08	Finley John David	Director & CEO, CFO	Sale	146.8K	$2.07	$303K	217.6K	View
2026-07-07	2026-07-08	Jones Mitchell Lawrence	Chief Medical Officer	Sale	51.9K	$2.05	$107K	94.0K	View

1–5 of 10

1 / 2

Recent News

Chamath Palihapitiya Says ‘Trust the Experts’ Approach To AI Is a Trap, Warns it Could Make COVID ‘Pale in Comparison’

Yahoo Finance · 2026-09-01

David Sacks Calls AI Regulation a 'Trojan Horse' to Shut Down Open Models, While Chamath Palihapitiya Warns US Investment Could 'Go Off of a Cliff'

Yahoo Finance · 2026-08-25

Palisade Bio Draws Bullish Call, Lead IBD Drug Advances Toward Phase 2

Yahoo Finance · 2026-07-27

Chamath Palihapitiya Sees ‘Very Obvious Industrial Logic’ in SpaceX Acquiring Tesla to Fund Elon Musk’s Broad Swath Of Projects

Yahoo Finance · 2026-07-20

Informational purposes only, not investment advice.